Suzanne Edwards

504 total citations
17 papers, 352 citations indexed

About

Suzanne Edwards is a scholar working on Economics and Econometrics, Applied Microbiology and Biotechnology and Pharmacology. According to data from OpenAlex, Suzanne Edwards has authored 17 papers receiving a total of 352 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Economics and Econometrics, 5 papers in Applied Microbiology and Biotechnology and 4 papers in Pharmacology. Recurrent topics in Suzanne Edwards's work include Pharmaceutical Economics and Policy (7 papers), Antibiotic Use and Resistance (5 papers) and Pharmaceutical industry and healthcare (4 papers). Suzanne Edwards is often cited by papers focused on Pharmaceutical Economics and Policy (7 papers), Antibiotic Use and Resistance (5 papers) and Pharmaceutical industry and healthcare (4 papers). Suzanne Edwards collaborates with scholars based in United Kingdom, United States and Germany. Suzanne Edwards's co-authors include Chantal Morel, John A. Ascher, Joseph R. Calabrese, Robert A. Leadbetter, Thomas R. Thompson, Stephan Harbarth, Marlieke E.A. de Kraker, Aidan Hollis, Enrico Baraldi and Caline Mattar and has published in prestigious journals such as Current Opinion in Microbiology, Clinical Microbiology and Infection and Bipolar Disorders.

In The Last Decade

Suzanne Edwards

16 papers receiving 338 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Suzanne Edwards United Kingdom	8	173	70	60	48	41	17	352
Su Young Lee South Korea	11	95 0.5×	132 1.9×	115 1.9×	189 3.9×	6 0.1×	38	660
Caline Mattar United States	7	32 0.2×	28 0.4×	74 1.2×	35 0.7×	24 0.6×	10	539
A. Tekle Saudi Arabia	12	50 0.3×	29 0.4×	15 0.3×	17 0.4×	61 1.5×	23	320
Mercedes Delgado-Valverde Spain	11	34 0.2×	125 1.8×	97 1.6×	238 5.0×	22 0.5×	36	450
Joseph M. Severs United States	7	141 0.8×	35 0.5×	7 0.1×	25 0.5×	11 0.3×	8	515
Jitender Sethi United States	5	120 0.7×	104 1.5×	52 0.9×	201 4.2×	12 0.3×	8	406
Thea Brennan-Krohn United States	14	27 0.2×	81 1.2×	49 0.8×	185 3.9×	6 0.1×	21	416
Anna Petersson Sweden	12	20 0.1×	119 1.7×	10 0.2×	73 1.5×	11 0.3×	19	546
Silvia Novío Spain	14	32 0.2×	24 0.3×	22 0.4×	9 0.2×	32 0.8×	29	393
Vassiliki Gennimata Greece	10	13 0.1×	17 0.2×	25 0.4×	69 1.4×	16 0.4×	16	299

Countries citing papers authored by Suzanne Edwards

Since Specialization

Citations

This map shows the geographic impact of Suzanne Edwards's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Suzanne Edwards with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Suzanne Edwards more than expected).

Fields of papers citing papers by Suzanne Edwards

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Suzanne Edwards. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Suzanne Edwards. The network helps show where Suzanne Edwards may publish in the future.

Co-authorship network of co-authors of Suzanne Edwards

This figure shows the co-authorship network connecting the top 25 collaborators of Suzanne Edwards. A scholar is included among the top collaborators of Suzanne Edwards based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Suzanne Edwards. Suzanne Edwards is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

17 of 17 papers shown

Otto-Knapp, Ralf, Suzanne Edwards, Giorgi Kuchukhidze, et al.. (2024). Availability of drugs for the treatment of multidrug-resistant/rifampicin-resistant tuberculosis in the World Health Organization European Region, October 2023. Eurosurveillance. 29(17). 5 indexed citations

Årdal, Christine, et al.. (2021). National Facilitators and Barriers to the Implementation of Incentives for Antibiotic Access and Innovation. Antibiotics. 10(6). 749–749. 7 indexed citations

Mattar, Caline, et al.. (2020). An overview of the global antimicrobial resistance research and development hub and the current landscape. Current Opinion in Microbiology. 57. 56–61. 39 indexed citations

Morel, Chantal, et al.. (2020). Industry incentives and antibiotic resistance: an introduction to the antibiotic susceptibility bonus. The Journal of Antibiotics. 73(7). 421–428. 64 indexed citations

Buckingham, Christopher D., et al.. (2020). Towards Accessible Mental Healthcare through Augmented Reality and Self-Assessment Tools. International Journal of Online and Biomedical Engineering (iJOE). 16(4). 33–42. 6 indexed citations

Edwards, Suzanne & Chantal Morel. (2019). Learning from our mistakes: using key opportunities to remove the perverse incentives that help drive antibiotic resistance. Expert Review of Pharmacoeconomics & Outcomes Research. 19(6). 685–692. 4 indexed citations

Buckingham, Christopher D., et al.. (2019). Augmented Reality for Accessible Digital Mental Healthcare. 274–275. 3 indexed citations

Morel, Chantal & Suzanne Edwards. (2018). Encouraging Sustainable Use of Antibiotics: A Commentary on the DRIVE-AB Recommended Innovation Incentives. The Journal of Law Medicine & Ethics. 46(S1). 75–80. 3 indexed citations

Edwards, Suzanne, Chantal Morel, Reinhard Busse, & Stéphan Harbarth. (2018). Combatting Antibiotic Resistance Together: How Can We Enlist the Help of Industry?. Antibiotics. 7(4). 111–111. 18 indexed citations

10.

Morel, Chantal, Suzanne Edwards, & Stéphan Harbarth. (2017). Preserving the ‘commons’: addressing the sustainable use of antibiotics through an economic lens. Clinical Microbiology and Infection. 23(10). 718–722. 10 indexed citations

11.

Morel, Chantal, et al.. (2016). Co-development of antibiotics and diagnostics for bacterial infection.

12.

Lerche, Holger, et al.. (2015). Efficacy and safety of ezogabine/retigabine as adjunctive therapy to specified single antiepileptic medications in an open-label study of adults with partial-onset seizures. Seizure. 30. 93–100. 9 indexed citations

13.

Bowden, Charles L., Suzanne Edwards, & G. Evoniuk. (2008). Open-Label, Concomitant Use of Lamotrigine and Other Medications for Bipolar Disorder. CNS Spectrums. 13(1). 75–83. 6 indexed citations

14.

Calabrese, Joseph R., et al.. (2008). Lamotrigine in the acute treatment of bipolar depression: results of five double‐blind, placebo‐controlled clinical trials. Bipolar Disorders. 10(2). 323–333. 167 indexed citations

15.

Edwards, Suzanne, et al.. (1991). Adverse Experience Collection: Perspective from a Biological Development Program. Drug Information Journal. 25(2). 175–180. 3 indexed citations

16.

Edwards, Suzanne. (1985). Statistical methods for the analysis of adverse experience data from clinical trials of new drugs. NCSU Libraries Repository (North Carolina State University Libraries). 1 indexed citations

17.

Edwards, Suzanne & Nord Ce. (1972). Identification and characterization of micro-organisms isolated from infected primary teeth.. PubMed. 3(1). 15–8. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact